RB Global, Inc. (TSX:RBA)

Regulus Therapeutics Revenue

RB Global had revenue of $1.11B USD in the quarter ending March 31, 2025, with 4.12% growth. This brings the company's revenue in the last twelve months to $4.33B, up 2.27% year-over-year. In the year 2024, RB Global had annual revenue of $4.28B with 16.43% growth.

• Revenue (ttm): $4.33B
• Revenue Growth: +2.27%
• P/S Ratio: 4.45
• Revenue / Employee: $498.06K
• Employees: 8,690
• Market Cap: 27.67B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	4.28B	604.60M	16.43%
Dec 31, 2023	3.68B	1.95B	112.23%
Dec 31, 2022	1.73B	316.80M	22.36%
Dec 31, 2021	1.42B	39.74M	2.89%
Dec 31, 2020	1.38B	58.62M	4.45%